The score is held down primarily by worsening earnings in 2024–2025 and consistently negative cash flow, which weaken overall financial performance. Technical indicators are broadly neutral with only mild negative momentum, and valuation support is limited because the negative P/E reflects losses despite a modest dividend yield.
Positive Factors
Conservative Balance Sheet
No reported debt materially reduces financial risk and gives the company durable capacity to absorb underwriting volatility or investment stress. Over months, low leverage supports regulatory capital, preserves strategic optionality for reinsurance or opportunistic asset purchases, and limits insolvency risk.
Stable Revenue Base
A steady top line from in-force premiums and recurring products creates predictability in pricing, reserve planning and investment cash flows. That stability allows management to focus on margin restoration and expense control, reducing long-term business volatility versus cyclical revenue models.
Diversified Earnings Model
Dual earnings drivers—underwriting and investment spread—provide structural diversification. Premium inflows fund fixed-income portfolios that can generate durable spread income, while disciplined underwriting can improve margins independent of market swings, supporting multi-month resilience.
Negative Factors
Persistent Negative Cash Flow
Sustained operating and free cash outflows weaken financial flexibility and force reliance on investment realizations or capital actions. Over a multi-month horizon this limits ability to support new sales, pay claims from operating receipts, invest in technology/distribution, or withstand prolonged adverse mortality or market shocks.
Worsening Profitability
A swing to sustained losses and negative margins erodes capital and reduces internal funds for growth or dividends. If underwriting or reserve assumptions remain weak, management must pursue pricing, expense reduction, or capital measures, all structural actions that can constrain long-term earnings recovery.
Declining Return on Equity
A shift to negative ROE indicates the company is not earning its cost of capital on equity, signaling impaired capital efficiency. Over months this can pressure retained earnings, limit capacity to fund liabilities internally, and increase probability of capital management actions like cuts to dividends or external raises.
Kansas City Life Insurance Company (KCLI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$309.86M
Dividend Yield1.75%
Average Volume (3M)886.00
Price to Earnings (P/E)―
Beta (1Y)0.48
Revenue Growth-3.32%
EPS Growth-162.81%
CountryUS
Employees443
SectorFinancial
Sector Strength70
IndustryInsurance - Life
Share Statistics
EPS (TTM)0.10
Shares Outstanding9,683,000
10 Day Avg. Volume369
30 Day Avg. Volume886
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.47
Price to Sales (P/S)0.64
P/FCF Ratio-2.38
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit0.62
Enterprise Value/Ebitda-10.76
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kansas City Life Insurance Company Business Overview & Revenue Model
Company DescriptionKansas City Life Insurance Company provides insurance products and services in 49 states and the District of Columbia. It offers a portfolio of individual insurance, annuity, and group life and health insurance; and traditional life insurance, immediate annuities with life contingencies, supplementary contracts with life contingencies, and accident and health insurance. Kansas City Life Insurance Company was incorporated in 1985 and is based in Kansas City, Missouri.
How the Company Makes MoneyKCLI primarily makes money through (1) insurance underwriting income and (2) investment income on invested assets supporting policy liabilities and capital. Underwriting-related revenue comes from policyholder premiums collected on in-force policies; from these premiums, the company pays policy benefits and claims, increases reserves for future obligations, and incurs operating expenses (commissions, underwriting, policy administration). Profit (or loss) from underwriting depends on pricing adequacy, mortality and morbidity experience relative to assumptions, policy persistency/lapse behavior, expense control, and the level and timing of claims. Investment income is generated by investing premium inflows and existing reserves—typically in a portfolio of fixed-income securities and other permitted assets—earning interest, dividends, and realized gains/losses; the spread between earned investment returns and amounts credited/guaranteed to policyholders (where applicable), plus the return on the company’s own capital, is a major earnings driver for life insurers. Additional earnings may come from policy charges and fees embedded in certain products (if applicable), as well as reinsurance arrangements that can transfer portions of risk in exchange for premiums/ceded charges; specific partnership counterparties are null.
Kansas City Life Insurance Company Financial Statement Overview
Summary
Financials are pressured by deteriorating profitability (losses in 2024 that widened in 2025 with negative operating earnings and ~-4% net margin) and persistently negative operating/free cash flow (2021–2025, with a sharp outflow in 2025). The main offset is a conservative balance sheet with no reported debt and sizable equity, which reduces financial risk but does not fully compensate for weak earnings and cash generation.
Income Statement
38
Negative
Revenue has been relatively stable from 2020–2025 (roughly flat overall), but profitability has been inconsistent. After a strong 2023 (healthy profit and operating earnings), results deteriorated to losses in 2024 and widened further in 2025, with negative operating earnings and a ~-4% net margin in 2025. The combination of choppy earnings and recent losses weighs on the income statement score despite steady top-line levels.
Balance Sheet
74
Positive
The balance sheet shows no reported debt across the periods provided, which materially reduces financial risk. Equity is sizable relative to the company’s scale, and total assets have stayed broadly steady. That said, returns on equity swung from positive in 2023 to negative in 2024–2025, indicating that recent profitability weakness is eroding the quality of balance-sheet returns even if leverage remains low.
Cash Flow
27
Negative
Cash generation is a clear weak spot: operating cash flow and free cash flow are negative in most years shown (2021–2025), including a sharp outflow in 2025. While the reported free-cash-flow growth rate is positive in 2025, it is off a negative base and does not change the fact that cash flow remains meaningfully negative. Persistent cash outflows reduce financial flexibility and increase dependence on portfolio actions or capital management.
Breakdown
Dec 2025
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Income Statement
Total Revenue
485.45M
490.74M
494.97M
475.95M
494.65M
Gross Profit
485.45M
126.33M
120.51M
103.98M
100.83M
EBITDA
-28.02M
-2.80M
74.56M
-14.16M
20.89M
Net Income
-20.76M
-4.96M
54.92M
-16.22M
10.70M
Balance Sheet
Total Assets
4.89B
5.02B
4.64B
4.97B
5.43B
Cash, Cash Equivalents and Short-Term Investments
8.43M
274.35M
9.70M
2.27B
3.17B
Total Debt
0.00
0.00
0.00
0.00
0.00
Total Liabilities
4.23B
4.44B
4.44B
4.08B
4.20B
Stockholders Equity
665.58M
581.45M
609.36M
491.69M
830.43M
Cash Flow
Free Cash Flow
-130.81M
-59.67M
-51.45M
-54.87M
-46.95M
Operating Cash Flow
-130.55M
-58.37M
-50.54M
-54.33M
-46.32M
Investing Cash Flow
45.03M
-13.01M
-2.60M
-89.17M
-7.86M
Financing Cash Flow
85.85M
69.78M
55.07M
145.85M
52.40M
Kansas City Life Insurance Company Technical Analysis
Technical Analysis Sentiment
Positive
Last Price33.25
Price Trends
50DMA
32.76
Negative
100DMA
32.08
Positive
200DMA
31.82
Positive
Market Momentum
MACD
-0.14
Positive
RSI
50.42
Neutral
STOCH
75.54
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KCLI, the sentiment is Positive. The current price of 33.25 is above the 20-day moving average (MA) of 32.50, above the 50-day MA of 32.76, and above the 200-day MA of 31.82, indicating a neutral trend. The MACD of -0.14 indicates Positive momentum. The RSI at 50.42 is Neutral, neither overbought nor oversold. The STOCH value of 75.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KCLI.
Kansas City Life Insurance Company Peers Comparison
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026